Similarly, studies have also reported the tumor-promoting role of IGF2BP1, IGF2BP3, IGFBP6 and IGFL2 in several cancers such as hepatocellular carcinoma, pancreatic and prostate cancers [37–40]. Here, IGFL2 is linked to prostate cancer.